Kralovánszky J, Prajda N, Kerpel-Fronius S, Gál F, Szentirmay Z
Cancer Chemother Pharmacol. 1983;11(3):167-71. doi: 10.1007/BF00254198.
The influence of the treatment schedule of dianhydrogalactitol on its effect on the activity of mucosal enzymes in rat intestine was studied. The effect of a single high dose (10 mg/kg) was compared with that of repeated small doses (4 x 2.5 mg/kg) given at daily intervals. At 48 h after a single high dose the activities of thymidine kinase, which is a marker of dividing crypt cells, and of alkaline phosphatase, sucrase, maltase, xanthine oxidase, which are markers of mature enterocytes, were strongly depressed. Even 96 h after the treatment low enzyme activities could be observed. Repeated small doses caused milder enzyme inhibition and almost total recovery had occurred by 96 h after administration of the last dose. The results indicate that fractionation of drug administration can reduce the toxic side-effects on the intestinal mucosa and might be partly responsible for the higher therapeutic index of such schedules in experimental tumor models.
研究了双去水半乳糖醇治疗方案对其对大鼠肠道黏膜酶活性影响的作用。将单次高剂量(10毫克/千克)的效果与每日间隔给予的重复小剂量(4×2.5毫克/千克)的效果进行了比较。单次高剂量给药48小时后,作为增殖隐窝细胞标志物的胸苷激酶以及作为成熟肠上皮细胞标志物的碱性磷酸酶、蔗糖酶、麦芽糖酶、黄嘌呤氧化酶的活性均受到强烈抑制。即使在治疗96小时后仍可观察到酶活性较低。重复小剂量引起的酶抑制作用较轻,在最后一次给药96小时后几乎完全恢复。结果表明,药物分次给药可降低对肠黏膜的毒副作用,这可能是此类方案在实验性肿瘤模型中具有较高治疗指数的部分原因。